Cargando…

Correction: Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment

Detalles Bibliográficos
Autores principales:	Yu, Yongbo, Liang, Ye, Li, Dan, Wang, Liping, Liang, Zhijuan, Chen, Yuanbin, Ma, Guofeng, Wu, Hui, Jiao, Wei, Niu, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587236/ https://www.ncbi.nlm.nih.gov/pubmed/37857614 http://dx.doi.org/10.1038/s41420-023-01652-2

Ejemplares similares

Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2021)

Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
por: Ma, Guofeng, et al.
Publicado: (2021)

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ
por: Wang, Liping, et al.
Publicado: (2018)

Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1
por: Zhang, Zhao, et al.
Publicado: (2023)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
por: Wang, Liping, et al.
Publicado: (2021)

Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis
por: Sun, Ningchuan, et al.
Publicado: (2019)

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
por: Jiang, Xianjie, et al.
Publicado: (2019)

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)

Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression
por: Zhang, Zhilei, et al.
Publicado: (2023)

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2021)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours
por: Cheng, Ya Qi, et al.
Publicado: (2020)

The Interplay between Tumour Microenvironment Components in Malignant Melanoma
por: Amalinei, Cornelia, et al.
Publicado: (2022)

Educational video: the role of PD-L1 in the local tumour microenvironment
por: Preusser, Matthias, et al.
Publicado: (2017)

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Immunohistochemical profiling of the tumour microenvironment in borderline and malignant ovarian tumours in young women
por: O'Neill, Danielle, et al.
Publicado: (2023)

Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer
por: Chen, Yuanbin, et al.
Publicado: (2021)

Low glucose microenvironment of normal kidney cells stabilizes a subset of messengers involved in angiogenesis
por: de Laplanche, Elodie, et al.
Publicado: (2015)

Hypoxia-Driven Immune Escape in the Tumor Microenvironment
por: Vito, Alyssa, et al.
Publicado: (2020)

The Influence of Tumor Microenvironment on Immune Escape of Melanoma
por: Simiczyjew, Aleksandra, et al.
Publicado: (2020)

Malignant tumours of the kidney: imaging strategy
por: Smets, Anne M., et al.
Publicado: (2010)

Role of PD-1/PD-L1-mediated tumour immune escape mechanism and microsatellite instability in the BCG failure of high-grade urothelial carcinomas
por: SALMAN, Fadime Gül, et al.
Publicado: (2022)

Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
por: Wang, Nuo-Han, et al.
Publicado: (2022)

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
por: Bauer, Marcus, et al.
Publicado: (2021)

Epithelial-mesenchymal transition as strategic microenvironment mimicry for cancer cell survival and immune escape?
por: Qin, Jun-Hui, et al.
Publicado: (2016)

Tumor Microenvironment and Immune Escape in the Time Course of Glioblastoma
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Role of immune escape in different digestive tumours
por: Du, Xin-Zhu, et al.
Publicado: (2021)

USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade
por: Yang, Zhaojuan, et al.
Publicado: (2021)

The role of tumour microenvironment: a new vision for cholangiocarcinoma
por: Chen, Ziyan, et al.
Publicado: (2018)

Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
por: Zhou, Kaijian, et al.
Publicado: (2020)

Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion
por: Miller, Tim J., et al.
Publicado: (2018)

Regulation of PD-L1 expression in the tumor microenvironment
por: Yi, Ming, et al.
Publicado: (2021)

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Comparison of the Basal Cell Carcinoma (BCC) Tumour Microenvironment to Other Solid Malignancies
por: Zhang, Eliana-Ruobing, et al.
Publicado: (2023)

Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
por: Osipov, Arsen, et al.
Publicado: (2019)

Malignant Tumours of the Kidney: Report of a Case of Tubular Adenocarcinoma of the Kidney
por: Kini, M. G.
Publicado: (1944)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Case of Malignant Fibre-Cellular Tumour Involving the Ileum
por: Buchanan, A. B.
Publicado: (1864)

Cannot write session to /tmp/vufind_sessions/sess_uk5pbaqrn7qaid9v7be6efiq29